ALGS
#4314
Aligos Therapeutics, Inc. - Common stock
5.5 3 USD
+0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+3.56%
Variación mensual
+6.96%
Variación en los últimos 6 meses
-36.80%
Cambio anual
-43.51%
Cierres anteriores
5.3 4
Open
5.5 0
Mínimo
5.3 3
Máximo
5.5 7
Financials
- Market Capitalization 34.49 M
- Employee 82
- Founded 2018
- CEO N/A
- Website www.aligos.com
- Headquarter Delaware, United States
- FIGI BBG00QX7QH68
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.8
Relación precio/flujo de caja
21
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4277 |  CRVO CervoMed Inc. - Common Stock | 2.51 USD | -22.05% | -25.30% | -1.18% | -68.35% | 37.95 M USD | ||
| 4287 |  LITS Lite Strategy, Inc. - Common Stock | 1.22 USD | -3.94% | -12.86% | +8.93% | -42.18% | 37.10 M USD | ||
| 4326 |  BCTX BriaCell Therapeutics Corp. - Common Shares | 3.87 USD | -1.28% | -7.86% | +8.10% | -66.70% | 33.67 M USD | ||
| 4330 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.06 USD | -2.75% | -11.67% | -25.35% | +1.92% | 33.33 M USD |